Combining Diagnostic Imaging and Pathology for Improving Diagnosis and Prognosis of Cancer

Figure 1

Evaluation of in situ breast cancer biomarkers. Image showing (a) Ki67 nuclear expression in an infiltrating breast cancer, (b) expression of ER in an infiltrating breast cancer, (c) PR expression in an infiltrating breast cancer, and (d) HER2 expression (score 3) in an infiltrating breast cancer.

(a)

(b)

(c)

(d)